Mastocytosis
What's New
Last Posted: Jan 11, 2024
- A multi-center retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML.
Zhibo Zhang, et al. Blood advances 2024 0 - Diffuse cutaneous mastocytosis in a girl with M541L polymorphism in KIT gene: Response to treatment with imatinib.
Aniza Giacaman, et al. Anales de pediatria 2023 0 - Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals.
David González-de-Olano, et al. Allergy 2023 0 - An elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes: pathophysiological implications.
Laura Polivka, et al. The Journal of allergy and clinical immunology 2023 0 - Severe food allergy reactions are associated with ?-tryptase.
Abigail Lang, et al. The Journal of allergy and clinical immunology 2023 0 - Digital PCR: A Sensitive and Precise Method for KIT D816V Quantification in Mastocytosis.
Greiner Georg, et al. Clinical chemistry 2017 0 (3) 547-555 - Case Report: Unusual Manifestation of KIT Negative Systemic Mastocytosis.
Cáceres-Nazario Beatriz, et al. American journal of hematology/oncology 2017 0 (12) 24-27 - Hymenoptera-induced anaphylaxis: is it a mast cell driven hematological disorder?
Brockow Knut, et al. Current opinion in allergy and clinical immunology 2017 0 (5) 356-362 - Midostaurin: A Multiple Tyrosine Kinases Inhibitor in Acute Myeloid Leukemia and Systemic Mastocytosis.
Schlenk Richard F, et al. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 2018 0 199-214 - Refining the phenotype associated with GNB1 mutations: Clinical data on 18 newly identified patients and review of the literature.
Hemati Parisa, et al. American journal of medical genetics. Part A 2018 0 (11) 2259-2275
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 27, 2024
- Content source: